Loading...
PhD Jurij Trontelj

PhD Jurij Trontelj
no.: 23420 source: ARIS

researcher – active in research organisation
Phone number 01 475 95 00
  jurij.tronteljat signffa.uni-lj.si
Foreign language skills
Research activity

Code Science Field Subfield
1.09.00  Natural sciences and mathematics  Pharmacy   
Keywords
Biopharmacy, pharmacocinetics, pharmacogenomics
Bibliography Representative bibliographic units | Personal | COBISS+
source: COBISS
source: SICRIS
Points
801.68
A''
201.75
A'
516.82
A1/2
610.7
CI10
1,340
CImax
130
h10
20
A1
3.02
A3
1.06
Data for the last 5 years (citations for the last 10 years) on October 15, 2025; Data for score A3 calculation refer to period 2020-2024 (2019, 2020, 2021, 2022)
Data for ARIS tenders ( 23.05.2022 – Target research programmes, archive )
Database Linked records Citations Pure citations Average pure citations
WoS 83  1,514  1,324  15.95 
Scopus 80  1,617  1,421  17.76 
Mentoring junior researchers
source: ARIS
no. Name and surname Type Period Code
1 PhD Andrej Grobin   Bologna doctoral studies  10/1/2018 - 9/30/2022  52093 
Education
source: ARIS
Level of education Professional title Study subject Faculty Year
  B. Sc.     SI University of Ljubljana, Faculty of Pharmacy 2002 
Doctoral degree  Ph. D.     SI University of Ljubljana, Faculty of Pharmacy 2007 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Employments
source: ARIS
Type of employment Research org. Research group Date of employment Position Role Title
Full time employment (120%, RD:20%)  University of Ljubljana, Faculty of Pharmacy  Chair of Pharmaceutical Technology  1/1/2003  Assistant  Researcher  Assistant professor 
Research projects Legend
source: ARIS
no. Code Title Period Head No. of publications
1. N1-0363  Bisphenol A substitutes: health risks to the endocrine and cardiovascular systems (Acronim: BPAsubRisk)   3/1/2024 - 2/28/2027  PhD Marija Sollner Dolenc   1,806 
2. J7-4635  MitoCan - Preclinical development of new Mitochondrial ion channel inhibitors for Cancer therapy   10/1/2022 - 9/30/2026  PhD Lucija Peterlin Mašič   6,640 
3. J2-4480  Removal of selected antimicrobials by plasma-cavitation hybrid technology from water matrices of varying complexity (Causma)   10/1/2022 - 9/30/2025  PhD Martin Petkovšek   3,135 
4. J1-3030  MTAvsAMR: new MultiTargeting Antibiotics against AntiMicrobial Resistance   10/1/2021 - 9/30/2025  PhD Lucija Peterlin Mašič   1,070 
5. L3-3177  Safety evaluation of cannabidiols and implications for public health and consumers behaviour   10/1/2021 - 12/31/2024  PhD Alja Štern   5,119 
6. L1-3160  Development of highly concentrated protein formulations and evaluation of absorption kinetics after subcutaneous administration   10/1/2021 - 9/30/2024  PhD Iztok Grabnar   3,178 
7. J3-2517  Development of innate immune receptor-targeting chimeras as custom-tailored vaccine adjuvants   9/1/2020 - 12/31/2023  PhD Žiga Jakopin   2,442 
8. J3-9256  Development of NOD2 agonists and dual NOD2/TLR7 agonistic conjugates as novel vaccine adjuvants   7/1/2018 - 6/30/2022  PhD Žiga Jakopin   3,048 
9. V3-1636  Sistem odkrivanja novih psihoaktivnih snovi v Sloveniji (akronim SONDA) (Slovene)   10/1/2016 - 9/30/2018  PhD Miran Brvar   1,568 
10. J1-6744  Razvoj polimerov z molekularnimi odtisi in njihova uporaba na področju okoljske in bio-analitike (Slovene)   7/1/2014 - 6/30/2017  PhD Tina Kosjek   5,213 
11. J3-4313  Vpliv aktivnega transporta imatiniba in različnih genotipov pacientov na uspešnost terapije kronične mieloične levkemije (Slovene)   7/1/2011 - 6/30/2014  PhD Albin Kristl   3,298 
12. J1-0957  Pharmacogenetic study of raloxifene metabolism and transport   2/1/2008 - 1/30/2011  PhD Aleš Mrhar   2,034 
ARIS research and infrastructure programmes Legend
source: ARIS
Views history
Favourite